stem-cell

Cell Stem Cell impact factor is 20.4 with a 5-year JIF of 21.8. See the rank, trend, and what that number means before submission.

Toward the end of each year I make predictions for the stem cell and regenerative medicine field for the coming year. I’ve been doing this in some form for more than a dozen years. In today’s post I grade my 2025 predictions for the regenerative arena. Overall, the crystal ball didn’t disappoint even if the […] The post Grading my 25 stem cell & regenerative medicine predictions for 2025 appeared…

Cartilage regeneration has been a holy grail for the stem cell field for decades. It has mostly been just out of reach though. Even most unproven stem cell clinics have stopped claiming to regrow cartilage in joints. For instance, a typical clinic that now injects PRP or cells into arthritic knees doesn’t claim to regrow […] The post Weekly reads: cartilage regeneration, ferroptosis, Aspen Neuros…

After years of legal battles, the FDA has secured what appears to be a decisive federal court victory in its effort to regulate one type of stem cell clinic. This ruling has implications for other clinics too. The U.S. Supreme Court just declined to review a key case that the FDA had won on appeal […] The post FDA secures major win as SCOTUS lets stem cell clinic ruling stand appeared first on Th…

Both Japan’s regenerative medicine framework and the system of FDA-centric oversight here in the US have allowed large numbers of unproven stem cell clinics to flourish. While the US stem cell clinic problem has gotten major attention, many in the field may not realize that there may be hundreds of unproven clinics that offer biologics […] The post Woman dies after unproven regenerative medicine …

It’s been a big couple of weeks of chaotic developments at the FDA including the ousting of CBER director Vinay Prasad. The Sarepta rollercoaster was tied to that. If such recent events are any indication of how the next 3+ years are going to play out at the agency, it’s going to be negative for […] The post Weekly reads: aging & stem cells, FDA disarray, bad stem cell headline of the week appear…

Stem cells can be serious business, but sometimes stories come along that are just fun like a lady running a marathon dressed as a stem cell. How cool is this: “Louise Cato from Somerset is doing the run to raise money for the charity Anthony Nolan, after her dad had a bone marrow transplant over […] The post Weekly reads: stem cell marathon, Ray Therapeutics, stem cells making you fat? appeared …

I had a feeling late last year that I’d frequently be writing about RFK Jr. and his impact on the FDA. However, I didn’t realize some of that would be writing for STAT News. As I mentioned a few days ago, I now have a new regular column over there. I thought the column would […] The post Weekly reads: RFK Jr. stem cell summit, FDA OKs eye cell therapy, cartilage repair appeared first on The Niche…

Did you predict the major events in the stem cell and regenerative medicine field this year? I tried and today’s post are the grades on my predictions. Prediction is a key part of being a scientist even if we may not think about it that much. For instance, we have to try to predict what […] The post Grading my 20 stem cell & regenerative medicine predictions for 2024 appeared first on The Niche .

After a bit of a hiatus in 2024, our  list of regenerative medicine and stem cell meetings returns for 2025. I’m noticing a lot of great stem cell meetings already scheduled for 2025. With the pandemic being less of an ever-present thing, most meetings are now only in-person these days. In a way, the hybrid […] The post 2025 regenerative medicine and stem cell meetings list appeared first on The …

There should be more stem cell awards. Why not recognize more scientists and advocates? I used to do a Stem Cell Person of the Year Award. I have thought about bringing it back. What do you think? Scroll through some past posts on the Stem Cell Person of the Year Award. ISSCR gives out stem […] The post Weekly reads: Rusty Gage & stem cell awards, ASCL1, stem cells for a vulture appeared first on…

New research on stem cell patches is exciting. However, more broadly, “stem cell patches” can mean very different things. What I’m talking about here are the types of patches that can repair holes or other problems with tissues. This is a powerful regenerative approach. In contrast, I’m not a fan of the type of stem cell […] The post Weekly reads: stem cell patches, helicase editing, hearing loss…

Back in late August, Liveyon leader John Kosolcharoen pleaded to federal charges on stem cells. What was Liveyon? Liveyon was a splashy umbilical cord stem cell supplier company. I don’t know if the company is still active now. One of its core products ended up sending dozens of people to the hospital due to contamination […] The post Liveyon made $21.6 million says DOJ; leader gets 3 years priso…

It’s always fun to see startups with cool ideas in the regenerative medicine space and a new one called GC Therapeutics got some nice coverage this week. What do you think the name of this firm stands for? I have one main idea I mention below. Before we jump into it, I want to introduce […] The post Weekly reads: George Church’s stem cell startup GC Therapeutics, coral for knees, blast from the p…

Some of you might remember the stem cell clinic firm R3 Stem Cell. I have major concerns about some of what they are marketing including in the U.S. I was reminded of R3 Stem Cell again just now. The Associated Press (AP) ran a PR on R3 Stem like it was a news story.  I […] The post Media like the AP promote unproven stem cell clinics such as R3 Stem Cell appeared first on The Niche .

Stem cell hype is a big problem these days. It’s been going on for decades. Even some generally good citizens of the stem cell and regenerative medicine arena engage in it at times. Maybe a few of them don’t even realize what they are doing. I think a few journalists occasionally fall into the hype […] The post Recommended reads: 3 infected in Mexico, stem cell hype, hearing restoration appeared …

Looking for some stem cell good news? You’ll like today’s post. One mission of this blog The Niche is to promote rigorous science-based regenerative medicine, which can lead to investigating and writing about not-so-upbeat stuff. Risky clinics. People getting hurt. Patient lawsuits. Serious FDA, FTC, or state AG regulatory developments. Such actions can be good […] The post Recent stem cell & reg…

What is immune rejuvenation? How would that work and what would be the benefits? As we age, our immune systems can change in unhelpful and unhealthy ways. One such change is a drift in the balance of production of different kinds of immune cells. Such a shift can lead to too many of some immune […] The post Weekly reads: immune rejuvenation, Cryo-Cell spin-off, stem cell patches, direct reprogram…

The Mayo Clinic does some great research on stem cells and regenerative medicine. However, at times I’ve felt that a few Mayo researchers are overexuberant. This mainly relates to certain not-yet-proven stem cell and related offerings. Fitting with that perception, the Mayo website also has some inaccurate stem cell content that leans toward overstating things. […] The post Key Mayo Clinic stem c…

Each year I make predictions for the stem cell and regenerative medicine field for the following year. Today’s prediction post is focused on what to expect in 2024. You can also see my stem cell predictions for 2023 and my grades on how I did. I also have made a video version of these predictions so please […] The post 20 stem cell & regenerative medicine predictions for 2024 appeared first on Th…